A5102841779- Cystic Fibrosis Research Advances
- Liver Disease Diagnosis and Treatment
- Liver Disease and Transplantation
- Neutropenia and Cancer Infections
- Kidney Stones and Urolithiasis Treatments
- Hepatocellular Carcinoma Treatment and Prognosis
- Pediatric Urology and Nephrology Studies
- Acute Lymphoblastic Leukemia research
- Prostate Cancer Diagnosis and Treatment
- Acute Myeloid Leukemia Research
- Lung Cancer Diagnosis and Treatment
- Alcohol Consumption and Health Effects
- Oral health in cancer treatment
- Prostate Cancer Treatment and Research
- Pancreatitis Pathology and Treatment
- Chemotherapy-related skin toxicity
- Antifungal resistance and susceptibility
- Renal and Vascular Pathologies
- Childhood Cancer Survivors' Quality of Life
- Glioma Diagnosis and Treatment
- Fungal Infections and Studies
- Organ Transplantation Techniques and Outcomes
- Meningioma and schwannoma management
- Musculoskeletal Disorders and Rehabilitation
- Mycobacterium research and diagnosis
Instituto de Investigación Marqués de Valdecilla
2023-2025
Marqués de Valdecilla University Hospital
2023-2025
Hospital Universitario Severo Ochoa
2025
Universidad San Ignacio de Loyola
2024
National University of San Marcos
2024
Hospital General de Niños Ricardo Gutierrez
2023
Hospital Universitario Río Hortega
2014-2020
Cystic Fibrosis Research Foundation
2017
Istituti di Ricovero e Cura a Carattere Scientifico
2017
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
2017
We aimed to perform an observational study of age at loss independent ambulation (LoA) and side-effect profiles associated with different glucocorticoid corticosteroid (GC) regimens in Duchenne muscular dystrophy (DMD).We studied 340 participants the Cooperative International Neuromuscular Research Group Natural History Study (CINRG-DNHS). LoA was defined as continuous wheelchair use. Effects prednisone or prednisolone (PRED)/deflazacort (DFZ), administration frequency, dose were analyzed by...
Journal Article Patterns of Oropharyngeal and Fecal Flora in Patients with Acute Leukemia Get access V. Fainstein, Fainstein Department Developmental Therapeutics, Section Infectious Disease, M. D. Anderson Hospital Tumor Institute, Houston, Texas Please address requests for reprints to Dr. 6723 Bertner Avenue, 77030. Search other works by this author on: Oxford Academic PubMed Google Scholar Rodriguez, Rodriguez Turck, Turck G. Hermann, Hermann B. Rosenbaum, Rosenbaum P. Bodey The Diseases,...
Severe alcohol-associated hepatitis (sAH) is a well-characterized disease with high short-term mortality. However, there limited research on those "less severe condition" (moderate AH). This study aims to characterize in-depth patients moderate AH (mAH), including the performance of mortality scoring systems, key prognostic factors, and survival over time. A multicenter retrospective cohort (2009-2019) included mAH (MELD score ≤20 at admission). Cox regression receiver operating...
The effectiveness of miconazole was evaluated in 37 documented fungal infections, 32 which were major infections. All patients receiving therapy for advanced malignancy, with 28 having acute leukemia. overall cure rate 41% and it also Nine 22 Candida albicans infections cured, 3 11 tropicalis cured. A total 183 who received presumed or infection toxicity. Nausea vomiting central nervous system toxicity the most common side effects, occurring 25 16% patients, respectively. Overall, drug...
Two new aminoglycoside antibiotics, tobramycin and amikacin, were compared in a randomized study of the treatment infections patients with cancer. For identified infections, response rate for was 60% amikacin 64%. Pneumonia, urinary tract infection, septicemia most frequent infections. Most (78%) pathogens gram-negative bacilli; Klebsiella pneumoniae, Escherichia coli, Pseudomonas aeruginosa frequently isolated organisms. When only due to bacilli considered, 67% responded 69% amikacin. All...
The administration of two chemoimmunotherapy programs to 103 consecutive patients with metastatic colorectal cancer resulted in improved survival for who achieved either objective tumor regressions or disease stabilization more than 8 weeks. Objective regression was observed 47% treated the Ftorafur-methyl-CCNU-methotrexate-Bacillus Calmette-Guerin (FTOR-MeM-BCG) program and 34% 5-fluorouracil-methotrexate-Baker's antifol (FU-M-BAF) +/- Levamisole program. combinated median duration...
Alcohol relapse after surviving an episode of alcohol-associated hepatitis (AH) is common. However, the clinical features, risk factors, and prognostic implications recurrent (RAH) are not well described.
Two metabolites of 2‐ 14 C‐cyclocytidine (cyclo‐C) were found in the plasma and urine a hydrolytic product, arabinosylcytosine (ara‐C), its deaminated arabinosyluracil (ara‐U), patients with cancer; 80% dose was 24 hr, 70% as cyclo‐C 10% ara‐C ara‐U. The disappearance curve is curvilinear; half‐life estimated from terminal phase 8 hr. By 6 level 0.35 µg/ml falls exponentially to 0.06 µ/ml by Plasma concentration ratios ara‐U are 0.1 0.3, 0.3 0.4, 1.1 1.3 at 10 min, 1 4 hr following...
Liver transplantation (LT) is a curative treatment for early-stage hepatocellular carcinoma (HCC) unsuitable surgical resection. However, tumor recurrence (TR) rates range from 8% to 20% despite strict selection criteria. The validation of new prognostic tools, such as pre-MORAL or RETREAT risks, necessary improve prediction. A retrospective study was conducted at Marqués de Valdecilla University Hospital in Cantabria, Spain, between 2010 and 2019 determine the rate TR LT patients identify...